Skip to content

Price / book at other companies

Baxter International logo
Baxter InternationalBAX
1.4×-1.0×
DaVita logo
DaVitaDVA
101.3×+92.2×
Medtronic logo
MedtronicMDT
2.1×-0.1×
Haemonetics logo
HaemoneticsHAE
3.3×-0.6×
CorMedix logo
CorMedixCRMD
1.2×-2.3×
Teladoc Health logo
Teladoc HealthTDOC
0.7×-0.2×

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-77.6%
Enterprise value$151.13M-63.6%
P/S0.7×-2.3×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Calculated from Outset Medical, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s price / book?
Outset Medical, Inc. (OM) reported price / book of 0.6× in Q1 2026.
How has Outset Medical, Inc.'s price / book changed year-over-year?
Outset Medical, Inc.'s price / book decreased by 45.4% year-over-year, from 1.2× to 0.6×.
What is the long-term trend for Outset Medical, Inc.'s price / book?
Over 5 years (2020 to 2025), Outset Medical, Inc.'s price / book has grown at a -57.1% compound annual growth rate (CAGR), from 36.4× to 0.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.